Alana Willen

Alana Willen serves as the Director of Financial Planning and Analysis at MedImpact Healthcare Systems, Inc. since February 2024, focusing on the integration of financial activities following the acquisition of Elixir. Previously, Alana held the same title at Elixir from April 2022 to February 2024, where efforts led to a significant improvement in EBITDA from $113M to $136M. Prior roles include Financial Planning and Analysis Manager at Latham, where Alana contributed to the company's transition to a public company, and Operational Finance Planning & Strategy Manager at Aramark, overseeing major cost reduction initiatives. Alana's career also includes positions at Stryker, Independence Blue Cross, Element Financial, and Grant Thornton, with an educational background in Finance from Penn State University.